SMS001

paclitaxel · ToLymph Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SMS001, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer [Phase 2]